Search results
Results from the WOW.Com Content Network
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Escherichia coli bacteria, which are often utilized in production of pharmaceutical products. Biotechnology is the use of living organisms to develop useful products. Biotechnology is often used in pharmaceutical manufacturing. Notable examples include the use of bacteria to produce things such as insulin or human growth hormone.
The characterisation of a biological medicinal product is a combination of testing the active substance and the final medicinal product together with the production process and its control. For example: Production process – it can be derived from biotechnology or from other technologies.
A recent study found that a class of medications called SGLT-2 inhibitors—which does not include Ozempic or similar drugs like Zepbound—significantly lowered the risk of dementia in people ...
Those with a narrow margin are more difficult to dose and administer, and may require therapeutic drug monitoring (examples are warfarin, some antiepileptics, aminoglycoside antibiotics). Most anti-cancer drugs have a narrow therapeutic margin: toxic side-effects are almost always encountered at doses used to kill tumors.
The longer an individual had been taking the drug, the greater the protective effect was. ... Comparing diabetes drugs’ effect on dementia risk. To investigate the drug’s links to dementia ...
Janssen Biotech: non-small cell lung cancer with EGFR exon 20 insertion mutations Sotorasib: Amgen: non-small cell lung cancer with KRAS G12C mutation Avapritinib: Blueprint Medicines Corp: granted for two indications: mast cell leukemia and advanced systemic mastocytosis: Belumosudil: Kadmon Pharmaceuticals: chronic graft-versus-host disease ...
A dementia charity has hailed a “historic moment” in Alzheimer’s research as a new drug has been found to reduce memory decline among patients with early-stage disease.